Holista Colltech Enters Into Binding Ovine Collagen Supply Agreement with US Pharmaceutical Firm, Shares Rise 8%

MT Newswires Live

Aug 26, 2025

Holista Colltech (ASX:HCT) entered into a binding supply and development deal with Regenerex Pharma to exclusively manufacture and supply its proprietary ovine collagen, including the 300 kDa intact collagen and nano-collagen technologies, for Regenerex's use in the development, clinical testing, and global distribution of advanced wound care products, according to a Tuesday Australian bourse filing.

Both companies will collaborate on new applications of nano-collagen in advanced wound care, with joint ownership of any resulting intellectual property. The agreement runs for the life of the relevant patents.

The agreement carries minimum purchase commitments for Regenerex of $50,000 in 2025, scaling to $3 million in 2026, $6 million in 2027, and $9 million annually from 2028 onwards.

Its shares rose 8% in recent trading on Tuesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2562238203"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2562238203\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2562238203?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-26 11:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2562238203","market":"fut","top_or_hot":-1,"title":"Holista Colltech Enters Into Binding Ovine Collagen Supply Agreement with US Pharmaceutical Firm, Shares Rise 8%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/HCT.AU\">Holista Colltech</a> (ASX:HCT) entered into a binding supply and development deal with Regenerex Pharma to exclusively manufacture and supply its proprietary ovine collagen, including the 300 kDa intact collagen and nano-collagen technologies, for Regenerex's use in the development, clinical testing, and global distribution of advanced wound care products, according to a Tuesday Australian bourse filing.</p><p>Both companies will collaborate on new applications of nano-collagen in advanced wound care, with joint ownership of any resulting intellectual property. The agreement runs for the life of the relevant patents.</p><p>The agreement carries minimum purchase commitments for Regenerex of $50,000 in 2025, scaling to $3 million in 2026, $6 million in 2027, and $9 million annually from 2028 onwards.</p><p>Its shares rose 8% in recent trading on Tuesday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Holista Colltech Enters Into Binding Ovine Collagen Supply Agreement with US Pharmaceutical Firm, Shares Rise 8%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHolista Colltech Enters Into Binding Ovine Collagen Supply Agreement with US Pharmaceutical Firm, Shares Rise 8%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-26 11:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/HCT.AU\">Holista Colltech</a> (ASX:HCT) entered into a binding supply and development deal with Regenerex Pharma to exclusively manufacture and supply its proprietary ovine collagen, including the 300 kDa intact collagen and nano-collagen technologies, for Regenerex's use in the development, clinical testing, and global distribution of advanced wound care products, according to a Tuesday Australian bourse filing.</p><p>Both companies will collaborate on new applications of nano-collagen in advanced wound care, with joint ownership of any resulting intellectual property. The agreement runs for the life of the relevant patents.</p><p>The agreement carries minimum purchase commitments for Regenerex of $50,000 in 2025, scaling to $3 million in 2026, $6 million in 2027, and $9 million annually from 2028 onwards.</p><p>Its shares rose 8% in recent trading on Tuesday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HCT.AU","symbol_name":"HOLISTA COLLTECH LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2562238203","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2562238203","pubTimestamp":1756177857,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Holista Colltech  entered into a binding supply and development deal with Regenerex Pharma to exclusively manufacture and supply its proprietary ovine collagen, including the 300 kDa intact collagen and nano-collagen technologies, for Regenerex's use in the development, clinical testing, and global distribution of advanced wound care products, according to a Tuesday Australian bourse filing.Both companies will collaborate on new applications of nano-collagen in advanced wound care, with joint ownership of any resulting intellectual property. The agreement runs for the life of the relevant patents.The agreement carries minimum purchase commitments for Regenerex of $50,000 in 2025, scaling to $3 million in 2026, $6 million in 2027, and $9 million annually from 2028 onwards.Its shares rose 8% in recent trading on Tuesday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HCT.AU":"HOLISTA COLLTECH LTD","BK7111":"个人用品","BK7501":"新冠治疗股"},"translate_title":"Holista Colltech与美国制药公司签订具有约束力的羊胶原蛋白供应协议，股价上涨8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCT.AU":0.9},"content_text":"Holista Colltech (ASX:HCT) entered into a binding supply and development deal with Regenerex Pharma to exclusively manufacture and supply its proprietary ovine collagen, including the 300 kDa intact collagen and nano-collagen technologies, for Regenerex's use in the development, clinical testing, and global distribution of advanced wound care products, according to a Tuesday Australian bourse filing.Both companies will collaborate on new applications of nano-collagen in advanced wound care, with joint ownership of any resulting intellectual property. The agreement runs for the life of the relevant patents.The agreement carries minimum purchase commitments for Regenerex of $50,000 in 2025, scaling to $3 million in 2026, $6 million in 2027, and $9 million annually from 2028 onwards.Its shares rose 8% in recent trading on Tuesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}